DaVita (DVA) Medical Group Deal Finally Closes, Reit Outperform At William Blair
Tweet Send to a Friend
William Blair analyst Matt Larew reiterated an Outperform rating on DaVita (NYSE: DVA) after the company announced that the $4.34 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
